Andaman Medical was proud to participate in the China International Medical Equipment Fair (CMEF) Autumn Edition 2025, held from 26 to 29 September 2025 at the China Import and Export Fair Complex in Guangzhou. As one of the largest and most influential exhibitions in the global MedTech calendar, CMEF brought together thousands of medical device manufacturers, healthcare professionals and industry innovators from across Asia and beyond.
This year’s event provided an important platform for us to engage with Chinese manufacturers eager to understand the fastest and most effective pathways into Southeast Asia’s rapidly expanding healthcare markets.
Sharing Practical Insights for ASEAN Market Access
At CMEF Guangzhou 2025, Andaman Medical took the stage at the WeTalk Global Stage to deliver a focused session designed specifically for Chinese MedTech manufacturers. The presentation, titled “How to Fast-Track Entry into Southeast Asia: A Practical Guide for Chinese Medical Device Companies”, was held on 27 September 2025 from 3:00 PM to 4:00 PM.
During the session, our team shared practical insights on navigating ASEAN’s regulatory landscape, with a particular emphasis on how Chinese companies can leverage the China–Malaysia regulatory reliance framework to accelerate approvals and streamline multi-market expansion.
The presentation covered key topics including:
- how reliance pathways shorten approval timelines
- ways to reduce repetitive documentation across borders
- strategies to prepare for multi-market expansion
- considerations for long-term compliance in Southeast Asia
Our goal was to equip companies with a realistic, practical roadmap to enter ASEAN with clarity and confidence.
Strong Engagement From the CMEF Community
We were pleased to see strong attendance and active participation throughout the session. Manufacturers asked thoughtful questions about classification, reliance eligibility, documentation strategy and post-market requirements across the region.
The level of engagement reinforced a clear trend:
Chinese MedTech companies are increasingly prioritising Southeast Asia as a key growth market.
A Showcase of Global MedTech Innovation
As always, CMEF delivered an impressive showcase of technologies shaping the future of healthcare. Across multiple halls, visitors explored advancements in:
- medical imaging
- monitoring and electronic equipment
- in-vitro diagnostics
- medical robotics and AI
- orthopedic and surgical technologies
- hospital automation and logistics
- digital health solutions
This cross-industry visibility enriches the conversations we have with manufacturers and ensures our regulatory support stays aligned with emerging technologies and market needs.
Supporting Chinese Manufacturers Expanding Into ASEAN
As manufacturers look outward to new markets, Andaman Medical remains committed to guiding Chinese companies through every aspect of Southeast Asia’s regulatory landscape. Our support includes:
- market-entry strategy and regulatory planning
- product classification and technical documentation guidance
- reliance pathway expertise, including China–Malaysia
- local authorised representation across ASEAN
- registration submissions and ongoing compliance management
With teams on the ground in Indonesia, Malaysia, Singapore, Thailand, Vietnam, Cambodia and the Philippines, we provide the in-country expertise required for smooth and compliant market access.
Looking Ahead
Our time at CMEF Guangzhou 2025 strengthened our belief that collaboration is essential for accelerating innovation across Asia. We look forward to continuing our conversations with manufacturers we met during the event and supporting their journey into Southeast Asia’s dynamic healthcare markets.
To learn more about how we can support your ASEAN expansion, connect with the Andaman Medical team.
👉 https://andamanmed.com/contact-us/
